IntuitiveSurgical News & Analysis
2 articles
Market Mood
Medtronic (MDT) Gains FDA Approval for New Robotic Surgery Platform
Medtronic (MDT) received FDA approval for its Hugo robotic-assisted surgery platform in December 2025, allowing it to perform urologic procedures. The first successful use occurred at Cleveland Clinic shortly after. This market is projected to grow from $13.8 billion in 2022 to $63.7 billion by 2035, yet Medtronic faces significant competition from Intuitive Surgical, which dominates the market with over 11,395 da Vinci systems installed globally. With a recent application for broader procedure approvals, Medtronic aims to expand its market presence but may have an uphill battle against a well-entrenched competitor.
Read More
Intuitive Surgical (ISRG) Trading at $483.46 with P/E Ratios of 59.99 and 47.39
As of March 16, 2026, Intuitive Surgical, Inc. (ISRG) shares were trading at $483.46. The company's trailing P/E was reported at 59.99, while the forward P/E stood at 47.39, according to Yahoo Finance. ISRG holds approximately 70% market share in robotic surgery and operates with a 12,000-system installed base. The company generates nearly 85% of its revenue from recurring sources and is part of a robotic surgery market projected to grow from $16 billion in 2026 to over $50 billion by 2035. This growth potential and strong market position may present a favorable long-term investment outlook.
Read More